Skip to main content
Jianmin Pharmaceutical Group Co., Ltd. logo

Jianmin Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 600976 ISIN · CNE000001HB7 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2022-09-01 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600976

About Jianmin Pharmaceutical Group Co., Ltd.

https://www.whjm.com/

Jianmin Pharmaceutical Group Co., Ltd. is a specialized pharmaceutical enterprise with a heritage dating back to 1637. The company focuses on the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern healthcare products. Its core portfolio emphasizes pediatric health, gynecological treatments, and chronic disease management. Key products include Longmu Zhuanggu Granules, recognized for supporting bone development and overall health in children. The group integrates traditional pharmacological wisdom with contemporary biotechnology and standardized production processes. Jianmin Group operates through a comprehensive value chain encompassing raw material sourcing, advanced manufacturing, and a distribution network. By leveraging its status as a time-honored brand, the company maintains a strong market position in the pediatric TCM segment while expanding its presence in general wellness and prescription drug markets.

Recent filings

Filing Released Lang Actions
健民集团2022年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2022 second extraordinary shareholders' meeting of the company. It includes information about the meeting date, location, attendance, voting results on various proposals including board member elections and stock incentive plans, and legal witness statements. The content focuses on the official voting results and decisions made during the shareholders' meeting rather than the meeting materials or presentations. The document is not a full annual or interim report, nor is it a management discussion or earnings release. It is not a proxy solicitation or a report publication announcement. The key characteristic is the official disclosure of voting results from a shareholders' meeting. Therefore, the document fits the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA). The document length (6147 characters) supports it being a full announcement rather than a brief notice or a report publication announcement. Confidence is high given the detailed voting tables and legal attestations related to the shareholder meeting resolutions.
2022-09-01 Chinese
健民集团关于回复中证中小投资者服务中心《股东质询建议函》的公告
Management Reports Classification · 95% confidence The document is a detailed announcement from a company responding to shareholder inquiries regarding a specific transaction involving the acquisition of a hospital. It discusses operational strategies, risks, market environment, and financial evaluation related to the transaction. The content focuses on management's explanation and justification of business decisions and outlook rather than presenting financial statements or earnings data. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is not a simple announcement of a report publication or voting results. The document fits best as a Management Report (MDA) because it provides management's detailed explanation of business trends, operational plans, and risk assessment related to a significant transaction.
2022-08-30 Chinese
健民集团2022年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is a detailed set of materials related to a shareholders' meeting of 健民药业集团股份有限公司 (Jianmin Pharmaceutical Group Co., Ltd.) held in 2022. It includes the agenda, voting procedures, proposals for approval, election of board members, and detailed information about a stock incentive plan and a related party transaction involving equity acquisition. The document is lengthy (15,000 characters) and contains comprehensive meeting materials, including proposals and voting methods, which are typical of shareholder meeting materials. It is not a transcript of a call, nor a financial report like an annual or interim report. It is not a simple announcement of voting results but the full meeting materials. The content aligns with the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting. Therefore, the document should be classified as AGM Information (AGM-R).
2022-08-24 Chinese
健民集团监事会关于2022年限制性股票激励计划激励对象名单的公示情况说明及核查意见
Regulatory Filings Classification · 90% confidence The document is a public announcement by the supervisory board of a company regarding the verification and disclosure of the list of incentive recipients under a 2022 restricted stock incentive plan. It includes details about the verification process, compliance with relevant laws and regulations, and confirmation that the incentive recipients meet the legal requirements. The document does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an official announcement related to management incentives and compliance verification, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Remuneration Information or Management Reports, and is not a full report or financial disclosure.
2022-08-23 Chinese
健民集团关于独立董事公开征集投票权的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a public announcement regarding the solicitation of voting rights by an independent director for a specific shareholder meeting. It details the voting period, the agenda items related to a restricted stock incentive plan, the procedures for submitting proxy voting authorization, and includes an authorization form for shareholders to delegate their voting rights. The document does not contain financial statements, audit results, or detailed financial performance data. It is not a report of voting results but rather a solicitation for proxy votes ahead of a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) as it pertains to voting rights and proxy solicitation related to shareholder voting, but since it is a solicitation and not the actual voting results, it is best classified under DVA which covers voting rights announcements and related notices.
2022-08-16 Chinese
浙江华方医护有限公司审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report'. It contains detailed audit opinions, responsibilities of auditors and management, and extensive financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and notes. The document references audit standards and includes the auditor's signature and date. The length is substantial (15,000 characters), and it contains the full audit report and financial data, not just an announcement or certification. Therefore, this document fits the category of a standalone Audit Report / Information filing.
2022-08-16 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.